system for Wellgrow Industrial Estate for a period of 20 years. On 23 November 2017, signed an agreement for construction of Ultrafiltration (UF) water supply and center wastewater treatment system
and its subsidiary for Quarter 2 of 2019 ending on 30 June 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for
, which consists of Engineering, Procurement and Construction business (EPC), Water Treatment Plant, and Wastewater Treatment Plant. At present, the Company has participated in bidding for new projects
Company plans to focus on its core business, with expertise and experience, which consists of Engineering, Procurement and Construction business (EPC), Water Treatment Plant, and Wastewater Treatment Plant
Profit Margin9 8.4% 51.9% 1 Operating Revenue consists of Raw Water Sales, Industrial Water Sales, and Wastewater Treatment Services. 2 Other Utilities Revenue consists of Excessive Charge and Service Fees
conducting its business at a high standard of Good Corporate Governance practices, particularly regarding the rights and equitable treatment of its shareholders. It is our responsibility to enhance the
supply 41.56 31.25 32.99 - Installation of water production systems and construction of turnkey water treatment systems 29.25 3.40 760.29 Other income 1.94 6.50 (70.15) Total revenues 380.77 280.20 35.89
securities. This is to ensure fair treatment between retail investors and foreign institutional investors executing the clearing and settlement of securities through custodian which is a member of TCH. The